Skip to main content
Journal cover image

Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.

Publication ,  Journal Article
Guo, Y; Goetz, CG; Stebbins, GT; Mestre, TA; Luo, S
Published in: Mov Disord
March 2023

BACKGROUND: Regulatory recommendations favor outcomes combining objective and patient input. The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), the most commonly used scale in Parkinson's disease (PD), includes patient and investigator ratings in distinct parts, but original clinimetric analyses failed to confirm the validity of combining parts by simple summing. OBJECTIVES: The aim was to develop clinimetrically valid constructs for combining patient-reported Part 2 and investigator-rated Part 3 MDS-UPDRS scores. METHODS: Using 7888 MDS-UPDRS scores, we assessed construct validity of combined Part 2 and Part 3 items using exploratory factor analysis (EFA) and graded item response theory (IRT) with threshold criteria: comparative fit index ≥0.9 (EFA) and discrimination parameters ≥0.65 (IRT). RESULTS: The direct sum of Parts 2 + 3 failed to meet the threshold for a valid outcome of PD severity (comparative fit index, CFI = 0.855). However, a two-domain construct combining item scores for tremor and non-tremor domains from Parts 2 and 3 confirmed validity, meeting both EFA and IRT criteria as distinct but correlated indices of disease severity (CFI = 0.923; discrimination mean 2.197 ± 0.480 [tremor] and 1.737 ± 0.344 [non-tremor] domains). CONCLUSIONS: The sum of Parts 2 + 3 is not clinimetrically sound. However, considering tremor and non-tremor items of both Parts 2 and 3 as two outcomes results in a valid summary of PD motor severity that leverages simultaneous patient- and investigator-derived measures. This analytic application addresses regulatory prioritizations and retains the well-validated MDS-UPDRS items. In future interventional trials, we suggest that tremor and non-tremor components of PD motor severity from Parts 2 + 3 be monitored and analyzed to accurately detect objective changes that integrate the patient's voice. © 2023 International Parkinson and Movement Disorder Society.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mov Disord

DOI

EISSN

1531-8257

Publication Date

March 2023

Volume

38

Issue

3

Start / End Page

453 / 463

Location

United States

Related Subject Headings

  • Tremor
  • Severity of Illness Index
  • Parkinson Disease
  • Neurology & Neurosurgery
  • Mental Status and Dementia Tests
  • Humans
  • Factor Analysis, Statistical
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guo, Y., Goetz, C. G., Stebbins, G. T., Mestre, T. A., & Luo, S. (2023). Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings. Mov Disord, 38(3), 453–463. https://doi.org/10.1002/mds.29308
Guo, Yuanyuan, Christopher G. Goetz, Glenn T. Stebbins, Tiago A. Mestre, and Sheng Luo. “Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.Mov Disord 38, no. 3 (March 2023): 453–63. https://doi.org/10.1002/mds.29308.
Guo, Yuanyuan, et al. “Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.Mov Disord, vol. 38, no. 3, Mar. 2023, pp. 453–63. Pubmed, doi:10.1002/mds.29308.
Journal cover image

Published In

Mov Disord

DOI

EISSN

1531-8257

Publication Date

March 2023

Volume

38

Issue

3

Start / End Page

453 / 463

Location

United States

Related Subject Headings

  • Tremor
  • Severity of Illness Index
  • Parkinson Disease
  • Neurology & Neurosurgery
  • Mental Status and Dementia Tests
  • Humans
  • Factor Analysis, Statistical
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences